Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shuangzhe Lin

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|March 25, 2026
Bone Organoids: A Novel Tool for Modeling and Managing Skeletal Disorders in DiabetesShuangzhe Lin, Karthikeyan Narayanan, Deepak Vashishth
Ageing Research Reviews|March 28, 2018
Sirtuins in mitochondrial stress: Indispensable helpers behind the scenesShuangzhe Lin, Haiping Xing, Tongtong Zang, et al.
Advanced Drug Delivery Reviews|February 21, 2023
Advanced delivery systems for peptide antibioticsAngela Cesaro, Shuangzhe Lin, Norbert Pardi, et al.
Frontiers in Cell and Developmental Biology|June 7, 2021
Prolyl Endopeptidase Gene Disruption Improves Gut Dysbiosis and Non-alcoholic Fatty Liver Disease in Mice Induced by a High-Fat DietDaixi Jiang, Jianbin Zhang, Shuangzhe Lin, et al.
Experimental Animals|April 5, 2023
New murine model of alcoholic hepatitis in obesity-induced metabolic-associated fatty liver diseaseYuqing Cheng, Shuangzhe Lin, Tianyi Ren, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 7, 2020
Chronic hepatitis B and non-alcoholic fatty liver disease: Conspirators or competitors?Jianbin Zhang, Shuangzhe Lin, Daixi Jiang, et al.
Canadian Journal of Gastroenterology & Hepatology|October 1, 2025
Major Depression as a Catalyst for Nonalcoholic Fatty Liver Disease: Insights From a Comprehensive Mendelian Randomization StudyYinshi Su, Shuangzhe Lin, Ling She, et al.
Life Sciences|January 31, 2021
Prolyl endopeptidase disruption reduces hepatic inflammation and oxidative stress in methionine-choline-deficient diet-induced steatohepatitisJianbin Zhang, Daixi Jiang, Shuangzhe Lin, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|March 25, 2026
Bone Organoids: A Novel Tool for Modeling and Managing Skeletal Disorders in DiabetesShuangzhe Lin, Karthikeyan Narayanan, Deepak Vashishth
Ageing Research Reviews|March 28, 2018
Sirtuins in mitochondrial stress: Indispensable helpers behind the scenesShuangzhe Lin, Haiping Xing, Tongtong Zang, et al.
Advanced Drug Delivery Reviews|February 21, 2023
Advanced delivery systems for peptide antibioticsAngela Cesaro, Shuangzhe Lin, Norbert Pardi, et al.
Frontiers in Cell and Developmental Biology|June 7, 2021
Prolyl Endopeptidase Gene Disruption Improves Gut Dysbiosis and Non-alcoholic Fatty Liver Disease in Mice Induced by a High-Fat DietDaixi Jiang, Jianbin Zhang, Shuangzhe Lin, et al.
Experimental Animals|April 5, 2023
New murine model of alcoholic hepatitis in obesity-induced metabolic-associated fatty liver diseaseYuqing Cheng, Shuangzhe Lin, Tianyi Ren, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 7, 2020
Chronic hepatitis B and non-alcoholic fatty liver disease: Conspirators or competitors?Jianbin Zhang, Shuangzhe Lin, Daixi Jiang, et al.
Canadian Journal of Gastroenterology & Hepatology|October 1, 2025
Major Depression as a Catalyst for Nonalcoholic Fatty Liver Disease: Insights From a Comprehensive Mendelian Randomization StudyYinshi Su, Shuangzhe Lin, Ling She, et al.
Life Sciences|January 31, 2021
Prolyl endopeptidase disruption reduces hepatic inflammation and oxidative stress in methionine-choline-deficient diet-induced steatohepatitisJianbin Zhang, Daixi Jiang, Shuangzhe Lin, et al.
Pageof 1